The phosphatonins and the regulation of phosphate transport and vitamin D metabolism

Journal of Steroid Biochemistry and Molecular Biology

Volumn 103, Issue 3-5, 2007, Pages 497-503

  Sommer, Stacy ^a   Berndt, Theresa ^a   Craig, Theodore ^a   Kumar, Rajiv ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

1, 25 Dihydroxyvitamin D (1 ,25(OH)2D); 25 Hydroxyvitamin D 1 hydroxylase; Autosomal dominant hypophosphatemic rickets (ADHR); Fibroblast growth factor 23; Matrix extracellular phosphoglycoprotein and fibroblast growth factor 7; Phosphate; Phosphate (Pi); Secreted frizzled related protein 4; Tumor induced osteomalacia; X linked hypophosphatemic rickets (XLH)

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; FRIZZLED PROTEIN; GLYCOPROTEIN; KERATINOCYTE GROWTH FACTOR; PHOSPHATE; VITAMIN D;

ARTICLE; ENZYME ACTIVITY; EPITHELIUM CELL; FIBROUS DYSPLASIA; HORMONE ACTION; HUMAN; HYPERCALCEMIA; HYPOPHOSPHATEMIA; MEMBRANE TRANSPORT; NONHUMAN; OSTEOMALACIA; PHOSPHATURIA; PROTEIN EXPRESSION; VITAMIN D METABOLISM;

ANIMALS; BIOLOGICAL FACTORS; BIOLOGICAL TRANSPORT; DIET; FIBROBLAST GROWTH FACTORS; HOMEOSTASIS; HUMANS; KIDNEY; PHOSPHATES; PHOSPHORUS; PROTO-ONCOGENE PROTEINS; VITAMIN D;

MUS;

EID: 33947132702     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.11.010     Document Type: Article

References (55)

1. Cohen P. The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58 (1989) 453-508
2. Hubbard S.R., and Till J.H. Protein tyrosine kinase structure and function. Annu. Rev. Biochem. 69 (2000) 373-398
3. Hunter T., and Cooper J.A. Protein-tyrosine kinases. Annu. Rev. Biochem. 54 (1985) 897-930
4. Krebs E.G., and Beavo J.A. Phosphorylation-dephosphorylation of enzymes. Annu. Rev. Biochem. 48 (1979) 923-959
5. Neuman W. In: Urist M.R. (Ed). Fundamental and Clinical Bone Physiology (1980), JB Lippincott Co., Philadelphia 83-107
6. Knochel J.P. The pathophysiology and clinical characteristics of severe hypophosphatemia. Arch. Intern. Med. 137 (1977) 203-220
7. Knochel J.P., Barcenas C., Cotton J.R., Fuller T.J., Haller R., and Carter N.W. Hypophosphatemia and rhabdomyolysis. Trans. Assoc. Am. Physicians 91 (1978) 156-168
8. 3. Endocr. Rev. 1 (1980) 258-267
9. Kumar R. Phosphatonin-a new phosphaturetic hormone? (lessons from tumour-induced osteomalacia and X-linked hypophosphataemia). Nephrol. Dial Transplant 12 (1997) 11-13
10. Kumar R. Tumor-induced osteomalacia and the regulation of phosphate homeostasis. Bone 27 (2000) 333-338
11. Kumar R., and Riggs B. In: Urist M. (Ed). Fundamental and Clinical Bone Physiology (1980), JB Lippincott & Co., Philadelphia 394-406
12. M. Kornmann, H.G. Beger, M. Korc, Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis, Pancreas 17 (1998) 169-175.
13. Slatopolsky E., and Bricker N.S. The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int. 4 (1973) 141-145
14. Slatopolsky E., Caglar S., Gradowska L., Canterbury J., Reiss E., and Bricker N.S. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake. Kidney Int. 2 (1972) 147-151
15. Slatopolsky E., Gradowska L., Kashemsant C., Keltner R., Manley C., and Bricker N.S. The control of phosphate excretion in uremia. J. Clin. Invest. 45 (1966) 672-677
16. Slatopolsky E., Robson A.M., Elkan I., and Bricker N.S. Control of phosphate excretion in uremic man. J. Clin. Invest. 47 (1968) 1865-1874
17. Berndt T., and Knox F. In: Seldin D.A.G. (Ed). The kidney: physiology and pathophysiology (1992), Raven Press, New York 2511-2532
18. Berndt T.J., Schiavi S., and Kumar R. Phosphatonins and the regulation of phosphorus homeostasis. Am. J. Physiol. Renal Physiol. 289 (2005) F1170-F1182
19. Markovich D., Verri T., Sorribas V., Forgo J., Biber J., and Murer H. Regulation of opossum kidney (OK) cell Na/Pi cotransport by Pi deprivation involves mRNA stability. Pflugers Arch. 430 (1995) 459-463
20. Segawa H., Kaneko I., Yamanaka S., Ito M., Kuwahata M., Inoue Y., Kato S., and Miyamoto K. Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice. Am. J. Physiol. Renal Physiol. 287 (2004) F39-F47
21. 3 in maintaining serum phosphorus and curing rickets. Proc. Natl. Acad. Sci. U.S.A. 71 (1974) 1040-1044
22. Tanaka Y., Frank H., and DeLuca H.F. Role of 1,25-dihydroxycholecalciferol in calcification of bone and maintenance of serum calcium concentration in the rat. J. Nutr. 102 (1972) 1569-1577
23. 3 in the rat. Endocrinology 92 (1973) 417-422
24. Tanaka Y., and Deluca H.F. The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus. Arch. Biochem. Biophys. 154 (1973) 566-574
25. Tanaka Y., Frank H., and DeLuca H.F. Intestinal calcium transport: stimulation by low phosphorus diets. Science 181 (1973) 564-566
26. 3. Physiol. Rev. 64 (1984) 478-504
27. Brown A.J., Koch M.J., and Coyne D.W. Oral feeding acutely down-regulates serum PTH in hemodialysis patients. Nephron. Clin. Pract. 103 (2006) c106-c113
28. 3 and dietary Pi in TPTX rats. Am. J. Physiol. 241 (1981) F123-F128
29. Puschett J.B., Fernandez P.C., Boyle I.T., Gray R.W., Omdahl J.L., and DeLuca H.F. The acute renal tubular effects of 1,25-dihydroxycholecalciferol. Proc. Soc. Exp. Biol. Med. 141 (1972) 379-384
30. 3: interactions with vasopressin and parathyroid hormone in the vitamin D-depleted rat. J. Lab. Clin. Med. 92 (1978) 895-903
31. 3 on membrane transport and intermediary metabolism. Miner Electrolyte Metab. 11 (1985) 62-68
32. Aurbach G.D., and Heath D.A. Parathyroid hormone and calcitonin regulation of renal function. Kidney Int. 6 (1974) 331-345
33. Aurbach G.D., Keutmann H.T., Niall H.D., Tregear G.W., O'Riordan J.L., Marcus R., Marx S.J., and Potts Jr. J.T. Structure, synthesis, and mechanism of action of parathyroid hormone. Recent Prog. Horm. Res. 28 (1972) 353-398
34. Chase L.R., and Aurbach G.D. Parathyroid function and the renal excretion of 3′5′-adenylic acid. Proc. Natl. Acad. Sci. U.S.A. 58 (1967) 518-525
35. Cai Q., Hodgson S.F., Kao P.C., Lennon V.A., Klee G.G., Zinsmiester A.R., and Kumar R. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N. Engl. J. Med. 330 (1994) 1645-1649
36. Drezner M.K. Hypophosphatemic rickets. Endocr. Dev. 6 (2003) 126-155
37. Drezner M.K. PHEX gene and hypophosphatemia. Kidney Int. 57 (2000) 9-18
38. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium, Nat Genet 11 (1995) 130-136.
39. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF-23. Nat. Genet. 26 (2000) 345-348
40. Schiavi S.C., and Kumar R. The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int. 65 (2004) 1-14
41. Schiavi S.C., and Moe O.W. Phosphatonins: a new class of phosphate-regulating proteins. Curr. Opin. Nephrol. Hypertens 11 (2002) 423-430
42. Bowe A.E., Finnegan R., Jan de Beur S.M., Cho J., Levine M.A., Kumar R., and Schiavi S.C. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem. Biophys. Res. Commun. 284 (2001) 977-981
43. Shimada T., Mizutani S., Muto T., Yoneya T., Hino R., Takeda S., Takeuchi Y., Fujita T., Fukumoto S., and Yamashita T. Cloning and characterization of FGF-23 as a causative factor of tumor-induced osteomalacia. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 6500-6505
44. Berndt T., Craig T.A., Bowe A.E., Vassiliadis J., Reczek D., Finnegan R., Jan De Beur S.M., Schiavi S.C., and Kumar R. Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J. Clin. Invest. 112 (2003) 785-794
45. Rowe P.S., Kumagai Y., Gutierrez G., Garrett I.R., Blacher R., Rosen D., Cundy J., Navvab S., Chen D., Drezner M.K., Quarles L.D., and Mundy G.R. MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone 34 (2004) 303-319
46. Carpenter T.O., Ellis B.K., Insogna K.L., Philbrick W.M., Sterpka J., and Shimkets R. Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J. Clin. Endocrinol. Metab. 90 (2005) 1012-1020
47. Shimada T., Kakitani M., Yamazaki Y., Hasegawa H., Takeuchi Y., Fujita T., Fukumoto S., Tomizuka K., and Yamashita T. Targeted ablation of FGF-23 demonstrates an essential physiological role of FGF-23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113 (2004) 561-568
48. White K.E., Carn G., Lorenz-Depiereux B., Benet-Pages A., Strom T.M., and Econs M.J. Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int. 60 (2001) 2079-2086
49. Campos M., Couture C., Hirata I.Y., Juliano M.A., Loisel T.P., Crine P., Juliano L., Boileau G., and Carmona A.K. Human recombinant endopeptidase PHEX has a strict S1′ specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein. Biochem. J. 373 (2003) 271-279
50. Larsson T., Nisbeth U., Ljunggren O., Juppner H., and Jonsson K.B. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int. 64 (2003) 2272-2279
51. Ferrari S.L., Bonjour J.P., and Rizzoli R. FGF-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J. Clin. Endocrinol. Metab. (2004)
52. Y. Nishida, H. Yamanaka-Okumura, Y. Taketani, T. Sato, K. Nashiki, H. Yamamoto, E. Takeda, Postprandial Changes of Serum Fibroblast Growth Factor 23(FGF-23). Levels on high phosphate diet in healthy men, J Bone Miner Res 20 (2005) S344.
53. Perwad F., Azam N., Zhang M.Y., Yamashita T., Tenenhouse H.S., and Portale A.A. Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice. Endocrinology 146 (2005) 5358-5364
54. Inoue Y., Segawa H., Kaneko I., Yamanaka S., Kusano K., Kawakami E., Furutani J., Ito M., Kuwahata M., Saito H., Fukushima N., Kato S., Kanayama H.O., and Miyamoto K. Role of the vitamin D receptor in FGF-23 action on phosphate metabolism. Biochem. J. 390 (2005) 325-331
55. 3 upregulates FGF-23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) G1036-G1042